• Page

Supplier Terms

• Page

Terms of Use – US

• Page

Terms of Use – EU (Français)

• Page

Terms of Use – EU (English)

• Page

Terms of Use – Australia

• Page

Terms of Use – EU (Deutsch)

• News Post

Kristen DeAndrade Turns Her Lived Experience into Her Life’s Work

• News Post

PKU Advocate, Parent Shares Personal Experience with Early Diagnosis

• Page

Terms of Use – EU (Nederlands)

• Press Release

BioMarin Reports Fourth Quarter and Full Year 2024 Results; Sets Full Year 2025 Guidance

• Page

Global Compliance and Ethics Program

• News Post

Sergio Covarrubias Turns Passion for Genomic Medicine into Impact

• News Post

Greg Friberg Discusses Career Journey, What Brought Him to BioMarin

• Press Release

BioMarin, Pioneer in Phenylketonuria (PKU) and Gene Therapy, Receives FDA Fast Track Designation for PKU Investigational Gene Therapy, BMN 307

• Press Release

BioMarin Receives FDA Fast Track Designation for Phenoptin for PKU

• Press Release

BioMarin Named by CenterWatch as One of the Fastest Developers of Medicines

• Publication

Quality of life, physical functioning, and psychosocial function among patients with achondroplasia: a targeted literature review (tandfonline.com)

Constantinos Constantinides,Sarah H. LandisORCID Icon,James Jarrett,Jennifer Quinn, Penelope J. Ireland

• News Post

Driving Progress for Children with Achondroplasia

• Page

Clinical Trials

• Page

Patient Support